Singapore Sepsis Diagnostics Market Size & Outlook
Singapore sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Singapore sepsis diagnostics market highlights
- The Singapore sepsis diagnostics market generated a revenue of USD 12.8 million in 2022 and is expected to reach USD 30.6 million by 2030.
- The Singapore market is expected to grow at a CAGR of 11.5% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 12.8 million |
| Market revenue in 2030 | USD 30.6 million |
| Growth rate | 11.5% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Singapore accounted for 1.3% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.2 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.06% in 2022. Horizon Databook has segmented the Singapore sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The rising incidence of sepsis in Singapore, driven by an aging population and the increasing prevalence of chronic conditions like diabetes and cardiovascular diseases, underscores the growing need for advanced diagnostic tools.
According to a study published by the Academy of Medicine, Singapore, in January 2024, around 16.6% of ICU patients are treated for sepsis, with a 30-day mortality rate nearing 20%.
This significant burden emphasizes the necessity for a national sepsis action plan to explore opportunities and develop strategies to alleviate the impact of sepsis on public health in Singapore. Addressing this challenge involves enhancing diagnostic capabilities, improving early detection, and implementing effective treatment protocols.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore sepsis diagnostics market size, by product, 2018-2030 (US$M)
Singapore Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
